Breaks Categories: News

FridaySep 16, 2022 12:07 pm

CannabisNewsBreaks – CannabisNewsWire to Heighten Visibility of Lift&Co. Expo Vancouver 2023

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands, including CannabisNewsWire, today announced that it will be collaborating with the organizers of Lift&Co. Expo. The industry-leading event will return to the Vancouver Convention Centre in Vancouver, BC, on Jan. 12-14, 2023. Lift&Co. Expo will feature 200+ exhibitors, industry professionals, seasoned investors, recreational and medicinal consumers and specialized media outlets. As a media partner, CannabisNewsWire will generate specialized content and further the distribution and publication through social media strategies and channel and digital partners to heighten the visibility of the conference, speakers and exhibitors. “We are always…

Continue Reading

FridaySep 16, 2022 11:04 am

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Featured on ‘Gamechangers LIVE’

Advanced Container Technologies (OTC: ACTX) was featured in a recent episode of “Gamechangers LIVE.” The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. Doug Heldoorn, ACTX chairman and CEO, and Shannon Illingworth joined the broadcast, hosted by executive coach and speaker Sergio Tigera, to discuss the origins of Advanced Container Technologies and the ways it is working to revolutionize farming practices. “When I was speaking with Shannon – I’ve known him for 15 years – we were…

Continue Reading

WednesdaySep 14, 2022 12:55 pm

CannabisNewsBreaks – CannabisNewsWire (CNW) to Shine the Spotlight on New Jersey’s First BYOC Event

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands within the InvestorBrandNetwork (“IBN”) today announced its engagement to serve as a media sponsor and official newswire for the 420 Expo. Presented by Wakit Grinders and hosted by cannabis icon Tommy Chong, the event is slated to take place at the New Jersey Convention & Exposition Center in Edison from Sept. 16-18, 2022. New Jersey’s first-ever BYOC (Bring your own Cannabis) consumer expo, the event is geared to shine a light on the cannabis community and alleviate the stigma around consumption. Organized shortly after…

Continue Reading

WednesdaySep 14, 2022 11:50 am

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX), GP Solutions Collaborate to Develop ‘GrowPod Habitat(TM)’ Systems

Advanced Container Technologies (OTC: ACTX) today announced that the company, in collaboration with GP Solutions, is developing a new series of GrowPods for home and commercial use. According to the update, the new “GrowPod Habitat(TM)” systems are smaller in size and will enable virtually anyone to grow their own food. The systems are designed for the consumer market, as well as for schools, churches, non-profits, and commercial organizations and businesses seeking to grow their own clean, nutritious food while also benefitting from a smaller size unit and reduced cost-of-entry to match their needs and budgets. “Developing this innovative smaller system…

Continue Reading

WednesdaySep 14, 2022 10:53 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $6M Private Placement Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common shares prices at $8.68 per share (or prefunded warrant in lieu thereof), totaling approximately $6 million. According to the announcement, INM also issued unregistered preferred investment options allowing the investors to purchase up to 1,382,490 additional common shares. The company observed that the unregistered investment options issued are exercisable upon issuance at an exercise price of $8.44 per share with an…

Continue Reading

TuesdaySep 13, 2022 1:00 pm

CannabisNewsBreaks – REZYFi Inc. Engages IBN for Corporate Communications Expertise

REZYFi, a cannabis-focused mortgage origination and specialized financing company, has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. As part of the client partner relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to build greater awareness for REZYFi. “REZYFi is taking charge as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still hesitant to serve the unique and evolving needs of the state-licensed…

Continue Reading

TuesdaySep 13, 2022 12:42 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Recognized for Strategic M&A Objectives at Benzinga Cannabis Capital Conference

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced its receipt of the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference in Chicago. “We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers,” said Luis Merchan, chairman and CEO of Flora. To view the full press release, visit https://cnw.fm/Rcquq About Flora Growth Corp. Flora is building a connected, design-led collective of plant-based wellness and lifestyle…

Continue Reading

MondaySep 12, 2022 1:25 pm

CannabisNewsBreaks – Bright Green Corporation (NASDAQ: BGXX) Announces Pricing of $10M Private Placement

Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced its entry into a securities purchase agreement with institutional investors to purchase 9,523,810 shares of common stock and warrants to purchase 9,523,810 shares of common stock, at a purchase price of $1.05 per share and accompanying warrant. The company expects approximately $10.0 million in gross proceeds from the offering, which, subject to the satisfaction of certain customary conditions, is…

Continue Reading

MondaySep 12, 2022 12:31 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters into $6M Securities Purchase Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of 691,245 of INM common shares; the shares will be sold at a purchase price of $8.68 per share in a private placement priced according to Nasdaq guidelines. According to the announcement, InMed will also issue unregistered preferred investment options that will allow investors in the offering to purchase more than 1.3 million common shares. The company noted that it anticipates gross proceeds from the placement,…

Continue Reading

FridaySep 09, 2022 10:13 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Update on Company Objectives and Programs

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company is working to complete enrollment in a phase 2 clinical program in epidermolysis bullosa (‘EB’) by the end of 2023, to advance its R&D efforts on a preclinical drug candidate in ocular disease and to investigate the potential of proprietary cannabinoid analogs in targeting specific diseases. The update included an observation that market demand for INM’s BayMedica naturally occurring cannabinoids is not progressing as anticipated,…

Continue Reading